Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication ‐ a prospective study for up to 10 years
Open Access
- 29 November 2017
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 47 (3) , 380-390
Abstract
Summary: Background: Atrophic gastritis and intestinal metaplasia are premalignant conditions for gastric cancer. Their reversibility by Helicobacter pylori eradication remains controversial.Aim: To evaluate the reversibility of atrophic gastritis and intestinal metaplasia by H. pylori eradication with long‐term follow‐up.Methods: 598 subjects were prospectively enrolled and followed for up to 10 years. They were categorised as H. pylori‐negative (n = 65), H. pylori non‐eradicated (n = 91), and H. pylori‐eradicated (n = 442). Histological assessment was performed for antrum and corpus by Sydney classification.Results: Histological follow‐up was performed regularly at 1, 2, 3‐4 and ≥5 years, with mean follow‐up of 1.07 ± 0.21, 2.29 ± 0.83, 3.93 ± 1.02, and 6.45 ± 1.28 years, respectively. Atrophic gastritis in antrum and corpus gradually and significantly (both P < .05 for all timepoints) improved only in the H. pylori‐eradicated group compared to that at baseline. Significant difference in atrophic gastritis between H. pylori‐eradicated and H. pylori‐negative groups disappeared from 1‐year follow‐up. Similarly, intestinal metaplasia in antrum and corpus improved significantly (both P < .05 for all timepoints) only in the H. pylori‐eradicated group in comparison with that at baseline. Significant difference in intestinal metaplasia between H. pylori‐eradicated and H. pylori‐negative groups disappeared from ≥5 years of follow‐up in the antrum and from 3 years of follow‐up in the corpus.Conclusion: H. pylori eradication may be a preventative strategy for intestinal‐type gastric cancer by regression of atrophic gastritis and intestinal metaplasia.Keywords
Funding Information
- National Research Foundation
- Ministry of Science, ICT and Future Planning
This publication has 67 references indexed in Scilit:
- Diagnosis and Epidemiology of Helicobacter pylori InfectionHelicobacter, 2013
- Effect of Eradication on Functional DyspepsiaJournal of Neurogastroenterology and Motility, 2013
- Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus ReportGut, 2012
- Predictive Factors for Improvement of Atrophic Gastritis and Intestinal Metaplasia After Helicobacter Pylori Eradication: A Three‐Year Follow‐Up Study in KoreaHelicobacter, 2012
- Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enoughAlimentary Pharmacology & Therapeutics, 2011
- The Role of Serum Pepsinogen and Gastrin Test for the Detection of Gastric Cancer in KoreaHelicobacter, 2008
- Screening for gastric cancer in Asia: current evidence and practiceThe Lancet Oncology, 2008
- American College of Gastroenterology Guideline on the Management of Helicobacter pylori InfectionAmerican Journal of Gastroenterology, 2007
- Serum pepsinogen concentration as a marker of Helicobacter pylori infection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levelsJournal of Gastroenterology, 2003
- Helicobacter pyloriInfection and the Development of Gastric CancerNew England Journal of Medicine, 2001